| Financial Year |
March 31 2023 |
| Monetary Funds |
2,286,202,048.78 |
| Held-for-trading Financial Assets |
1,463,622,906.33 |
| Notes Receivable |
-- |
| Accounts Receivable |
2,288,842,517.00 |
| Advances to Suppliers |
412,234,660.70 |
| Other Receivables |
217,154,888.26 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
2,359,919.59 |
| Dividend Receivable |
-- |
| Inventories |
14,615,751.87 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
299,695,436.61 |
| Total Current Assets |
6,994,117,722.03 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
19,102,185.08 |
| Long-term Equity Investment |
29,907,184.43 |
| Investment Properties |
-- |
| Fixed Assetes |
7,454,084,375.17 |
| Under-construction Projects |
1,590,588,659.41 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,188,648,739.05 |
| R&D expenses |
-- |
| Goodwill |
1,073,866,304.62 |
| Long-Term Deferred and Prepaid Expenses |
535,760,219.29 |
| Deferred Income Tax Assets |
172,992,057.78 |
| Other Non-Current Assets |
77,210,901.10 |
| Sub-Total of Non-Current Assets |
12,443,380,020.62 |
| Total Assets |
19,437,497,742.65 |
| Short-Term Loans |
394,780,081.27 |
| Trading Financial liabilities |
-- |
| Notes Payable |
20,802,099.28 |
| Accounts Payable |
1,547,419,993.79 |
| Accounts Received In Advance |
2,101,377.37 |
| Employee Compensation Payable |
13,907,699.53 |
| Taxes Payable |
21,533,328.02 |
| Interest Payable |
9,791,668.37 |
| Dividend Payable |
-- |
| Other payables |
142,161,729.96 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
325,789,002.62 |
| Other Current Liabilities |
5,513,032.95 |
| Sub-Total of Current Liabilities |
2,592,302,500.43 |
| Long-term Loans |
3,360,003,230.69 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
333,512,261.04 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
86,729,020.43 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
4,017,911,890.42 |
| Total Liabilities |
6,610,214,390.85 |
| Paid-In Capital(Or Share Stock) |
1,797,592,847.00 |
| Capital Surplus |
7,223,973,054.62 |
| Surplus Reserve |
138,705,340.74 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
3,119,603,664.78 |
| Minority Stockholder's Interest |
547,514,195.89 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
12,279,769,155.91 |
| Owner's Equity（Stockholder's Equity） |
12,827,283,351.80 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
19,437,497,742.65 |
